[go: up one dir, main page]

EP2745235A4 - Method of drug repositioning - Google Patents

Method of drug repositioning

Info

Publication number
EP2745235A4
EP2745235A4 EP12825157.6A EP12825157A EP2745235A4 EP 2745235 A4 EP2745235 A4 EP 2745235A4 EP 12825157 A EP12825157 A EP 12825157A EP 2745235 A4 EP2745235 A4 EP 2745235A4
Authority
EP
European Patent Office
Prior art keywords
drug repositioning
repositioning
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP12825157.6A
Other languages
German (de)
French (fr)
Other versions
EP2745235A1 (en
Inventor
Pankaj Agarwal
Lun Yang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Intellectual Property Development Ltd
Original Assignee
GlaxoSmithKline Intellectual Property Development Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline Intellectual Property Development Ltd filed Critical GlaxoSmithKline Intellectual Property Development Ltd
Publication of EP2745235A1 publication Critical patent/EP2745235A1/en
Publication of EP2745235A4 publication Critical patent/EP2745235A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N20/00—Machine learning
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N5/00—Computing arrangements using knowledge-based models
    • G06N5/04—Inference or reasoning models
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/30—Prediction of properties of chemical compounds, compositions or mixtures
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/70—Machine learning, data mining or chemometrics

Landscapes

  • Engineering & Computer Science (AREA)
  • Theoretical Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Computing Systems (AREA)
  • Data Mining & Analysis (AREA)
  • Software Systems (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Artificial Intelligence (AREA)
  • Mathematical Physics (AREA)
  • General Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Evolutionary Computation (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Computational Linguistics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Databases & Information Systems (AREA)
  • Primary Health Care (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP12825157.6A 2011-08-19 2012-08-17 Method of drug repositioning Withdrawn EP2745235A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161525467P 2011-08-19 2011-08-19
PCT/US2012/051257 WO2013028480A1 (en) 2011-08-19 2012-08-17 Method of drug repositioning

Publications (2)

Publication Number Publication Date
EP2745235A1 EP2745235A1 (en) 2014-06-25
EP2745235A4 true EP2745235A4 (en) 2015-05-27

Family

ID=47746776

Family Applications (1)

Application Number Title Priority Date Filing Date
EP12825157.6A Withdrawn EP2745235A4 (en) 2011-08-19 2012-08-17 Method of drug repositioning

Country Status (4)

Country Link
US (1) US20140193517A1 (en)
EP (1) EP2745235A4 (en)
CA (1) CA2845756A1 (en)
WO (1) WO2013028480A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9486419B2 (en) * 2013-04-17 2016-11-08 Ariel-University Research And Development Company CB2 receptor ligands for the treatment of psychiatric disorders
CN103251954A (en) * 2013-05-22 2013-08-21 罗国安 Diabetes treating compound medicine for reducing side effect of rosiglitazone and preparation method thereof
US9530095B2 (en) 2013-06-26 2016-12-27 International Business Machines Corporation Method and system for exploring the associations between drug side-effects and therapeutic indications
IN2014CH00676A (en) * 2014-02-13 2015-08-14 Infosys Ltd
US11037684B2 (en) 2014-11-14 2021-06-15 International Business Machines Corporation Generating drug repositioning hypotheses based on integrating multiple aspects of drug similarity and disease similarity
US10546019B2 (en) 2015-03-23 2020-01-28 International Business Machines Corporation Simplified visualization and relevancy assessment of biological pathways
US10839936B2 (en) 2015-11-02 2020-11-17 International Business Machines Corporation Evidence boosting in rational drug design and indication expansion by leveraging disease association
CN110297839B (en) * 2019-06-25 2022-04-12 中国人民解放军军事科学院军事医学研究院 Drug indication query method and device, computer equipment and storage medium
US11028264B2 (en) 2019-08-05 2021-06-08 International Business Machines Corporation Polylysine polymers with antimicrobial and/or anticancer activity
US11007216B2 (en) 2019-08-05 2021-05-18 International Business Machines Corporation Combination therapy to achieve enhanced antimicrobial activity
US11071739B1 (en) 2020-09-29 2021-07-27 Genus Lifesciences Inc. Oral liquid compositions including chlorpromazine
US20240212786A1 (en) * 2022-12-14 2024-06-27 POSTECH Research and Business Development Foundation Method of discovering novel anticancer drug using co-essentiality network, and an apparatus thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8489336B2 (en) * 2002-09-16 2013-07-16 Optimata Ltd. Techniques for purposing a new compound and for re-purposing a drug
JP2008520751A (en) * 2005-02-25 2008-06-19 テバ ファーマシューティカル インダストリーズ リミティド Tadalafil having a large particle size and method for preparing the same

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
EPO: "Mitteilung des Europ?ischen Patentamts vom 1. Oktober 2007 ?ber Gesch?ftsmethoden = Notice from the European Patent Office dated 1 October 2007 concerning business methods = Communiqu? de l'Office europ?en des brevets,en date du 1er octobre 2007, concernant les m?thodes dans le domaine des activit?s", JOURNAL OFFICIEL DE L'OFFICE EUROPEEN DES BREVETS.OFFICIAL JOURNAL OF THE EUROPEAN PATENT OFFICE.AMTSBLATTT DES EUROPAEISCHEN PATENTAMTS, OEB, MUNCHEN, DE, vol. 30, no. 11, 1 November 2007 (2007-11-01), pages 592 - 593, XP002498048, ISSN: 0170-9291 *
See also references of WO2013028480A1 *

Also Published As

Publication number Publication date
US20140193517A1 (en) 2014-07-10
WO2013028480A1 (en) 2013-02-28
CA2845756A1 (en) 2013-02-28
EP2745235A1 (en) 2014-06-25

Similar Documents

Publication Publication Date Title
EP2720719A4 (en) Method of selecting therapeutic indications
GB201110095D0 (en) Method of treatment
EP2773754A4 (en) Method of treatment
EP2717855A4 (en) Methods of treatment
GB2488674B (en) Catalyst and method of preparation
EP2596675A4 (en) Methods of maintaining multiple timing advance
EP2745235A4 (en) Method of drug repositioning
PL2800476T3 (en) Method of feeding
EP2760853A4 (en) Novel salts of alogliptin
PL3287131T3 (en) Therapeutic uses of ectoine
ZA201403739B (en) Methods of treatment with deferiprone
ZA201502595B (en) Therapeutic methods
IL222360A0 (en) Method of vaccination
EP2668260A4 (en) Method of modifying bacteria
SG11201403485VA (en) Method of Forming Boding Structure
EP2766862A4 (en) Method of managing products
GB201215942D0 (en) Method of treatent
EP2684869A4 (en) Preparation of 3-mercaptopropionates
GB2516380B (en) Catalyst and method of preparation
EP2782902A4 (en) Derivatives of phenoxyisobutyric acid
EP2791324A4 (en) Method of treatment
GB201119607D0 (en) Method of manufacture
GB201102475D0 (en) Method of reducing offset
GB2494923B (en) Set of support assemblies
GB201103044D0 (en) Method of treatment

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20140318

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

RA4 Supplementary search report drawn up and despatched (corrected)

Effective date: 20150423

RIC1 Information provided on ipc code assigned before grant

Ipc: G06G 7/58 20060101AFI20150417BHEP

Ipc: G06F 19/00 20110101ALI20150417BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20151124